Porphyrin binding and distortion and substrate specificity in the ferrochelatase reaction: the role of active site residues.

Journal of Molecular Biology
Tobias KarlbergSalam Al-Karadaghi

Abstract

The specific insertion of a divalent metal ion into tetrapyrrole macrocycles is catalyzed by a group of enzymes called chelatases. Distortion of the tetrapyrrole has been proposed to be an important component of the mechanism of metallation. We present the structures of two different inhibitor complexes: (1) N-methylmesoporphyrin (N-MeMP) with the His183Ala variant of Bacillus subtilis ferrochelatase; (2) the wild-type form of the same enzyme with deuteroporphyrin IX 2,4-disulfonic acid dihydrochloride (dSDP). Analysis of the structures showed that only one N-MeMP isomer out of the eight possible was bound to the protein and it was different from the isomer that was earlier found to bind to the wild-type enzyme. A comparison of the distortion of this porphyrin with other porphyrin complexes of ferrochelatase and a catalytic antibody with ferrochelatase activity using normal-coordinate structural decomposition reveals that certain types of distortion are predominant in all these complexes. On the other hand, dSDP, which binds closer to the protein surface compared to N-MeMP, does not undergo any distortion upon binding to the protein, underscoring that the position of the porphyrin within the active site pocket is crucial for ge...Continue Reading

References

Mar 1, 1991·Acta Crystallographica. Section A, Foundations of Crystallography·T A JonesM Kjeldgaard
Dec 31, 1980·Biochemical and Biophysical Research Communications·P R Ortiz de MontellanoG S Marks
Nov 30, 1981·Biochemical and Biophysical Research Communications·P R Ortiz de MontellanoG S Marks
Apr 9, 1998·Biophysical Journal·W JentzenJ A Shelnutt
Oct 3, 1998·Acta Crystallographica. Section D, Biological Crystallography·A T BrüngerG L Warren
Mar 8, 2000·Biochemistry·R FrancoJ A Shelnutt
Mar 8, 2000·Journal of Molecular Biology·D LecerofS Al-Karadaghi
Nov 13, 2002·Biochemistry·Tobias KarlbergSalam Al-Karadaghi
Jan 29, 2003·Proceedings of the National Academy of Sciences of the United States of America·Jun YinPeter G Schultz
Apr 2, 2003·Human Molecular Genetics·Emmanuel LesuisseAndrew Dancis
May 23, 2003·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·David LecerofSalam Al-Karadaghi
May 5, 2004·The Journal of Biological Chemistry·Taejin Yoon, J A Cowan
Dec 2, 2004·Acta Crystallographica. Section D, Biological Crystallography·Paul Emsley, Kevin Cowtan
Dec 17, 2004·Journal of the American Chemical Society·Swarnalatha VenkateshraoThomas G Spiro
Jan 12, 2005·Biochemistry·Heather A O'NeillGrazia Isaya
Feb 3, 2006·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Mattias D HanssonMats Hansson
Feb 14, 2006·Trends in Biochemical Sciences·Salam Al-KaradaghiGloria C Ferreira
Apr 13, 2006·Journal of Synchrotron Radiation·Y CereniusA Liljas
Jun 24, 2006·The Biochemical Journal·Zhen Shi, Gloria C Ferreira
Jan 31, 2007·Proceedings of the National Academy of Sciences of the United States of America·Amy MedlockWilliam N Lanzilotta
Sep 22, 2007·Journal of Molecular Biology·Amy E MedlockWilliam N Lanzilotta
Nov 6, 2010·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Mattias D HanssonMats Hansson

❮ Previous
Next ❯

Citations

Sep 22, 2009·The Journal of Biological Chemistry·Ruth E DavidsonJames D Reid
Jul 3, 2008·The Journal of Biological Chemistry·Gregory A HunterGloria C Ferreira
Dec 22, 2010·Proceedings of the National Academy of Sciences of the United States of America·Célia V RomãoMartin J Warren
Jun 23, 2009·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Borys SzefczykJosé A N F Gomes
Nov 6, 2010·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Mattias D HanssonMats Hansson
Jan 20, 2016·Archives of Biochemistry and Biophysics·Dulmini P BarupalaTimothy L Stemmler
Aug 26, 2009·Journal of Molecular Biology·Amy E MedlockWilliam N Lanzilotta
May 28, 2010·Protein Science : a Publication of the Protein Society·Gunhild LayerDirk W Heinz
Jul 1, 2009·Proceedings of the National Academy of Sciences of the United States of America·Sylvie LétofféCécile Wandersman
Jul 22, 2011·Journal of Porphyrins and Phthalocyanines·Ricardo FrancoGloria C Ferreira
Aug 20, 2011·Journal of Porphyrins and Phthalocyanines·Gregory A HunterGloria C Ferreira
Jan 27, 2017·Microbiology and Molecular Biology Reviews : MMBR·Harry A DaileyMartin J Warren
Jul 7, 2009·Metallomics : Integrated Biometal Science·Lalla Aicha BaClaus Jacob
Nov 13, 2019·Pharmaceutical Patent Analyst·Hermann Am Mucke
Jul 3, 2020·European Journal of Organic Chemistry·Elisabeth Sitte, Mathias O Senge
Sep 26, 2020·Biochimica Et Biophysica Acta. Molecular Cell Research·Gunhild Layer
May 9, 2012·Journal of Inorganic Biochemistry·Natalia de ValRobert R Crichton
Dec 1, 2019·Journal of Porphyrins and Phthalocyanines·Ariana YettLiliya A Yatsunyk
Nov 28, 2012·Journal of the American Chemical Society·John M NicoludisLiliya A Yatsunyk
Apr 29, 2020·ACS Central Science·Nathaniel P EndicottTimothy A Wencewicz
Oct 1, 2021·Angewandte Chemie·Francesco ArmillottaAlberto Verdini

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.